Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from SELB

SVB Leerink Sees Over 600% Upside For This Penny Biotech Stock

SVB Leerink initiated Selecta Biosciences Inc (NASDAQ:SELB) coverage with an Outperform rating and a price target of $7. The analysts view ImmTOR's approach to mitigate ADAs as de-risked by early clinical data from SEL-212 and believe that the ability to tame the immune response bodes well for ImmTOR's clinical potential in combination with…

Benzinga · Jun 6, 2022

Recap: Selecta Biosciences Q1 Earnings

Selecta Biosciences (NASDAQ:SELB) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 5, 2022

Earnings Outlook For Selecta Biosciences

Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Selecta Biosciences will report an earnings per share (EPS) of $-0.11.

Benzinga · May 4, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stocks Under $5 to Buy Now

Rising cases of chronic diseases and growing investments in research and development to find better cures for a wealth of maladies are expected to bolster the biotech industry’s growth. An aging population should also boost the demand for biotech products. Therefore, we think it could be wise to invest now…

StockNews.com · Apr 27, 2022

Selecta Biosciences's Return On Capital Employed Insights

According to Benzinga Pro, during Q4, Selecta Biosciences (NASDAQ:SELB) earned $12.24 million, a 168.4% increase from the preceding quarter. Selecta Biosciences also posted a total of $29.94 million in sales, a 22.56% increase since Q3.

Benzinga · Mar 14, 2022

Selecta Biosciences: Q4 Earnings Insights

Selecta Biosciences (NASDAQ:SELB) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 10, 2022

Earnings Preview: Selecta Biosciences

Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that Selecta Biosciences will report an earnings per share (EPS) of $-0.07.

Benzinga · Mar 9, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.